Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy

被引:75
作者
Schluger, NW [1 ]
Perez, D [1 ]
Liu, YM [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, Dept Med, New York, NY 10032 USA
关键词
AIDS; immunity; treatment; tuberculosis;
D O I
10.1378/chest.122.2.597
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To assess the restoration of immune responses to tuberculosis, as manifested by secretion of T-helper type 1 cytokines (interferon [IFN]-gamma, interleukin [IL]-12, and IL-2) ana T-helper type 2 cytokines (IL-10), in HIV-positive patients who receive antiretroviral therapy (ART). Design: Prospective cohort study. Setting: University hospital. Patients: Ten HIV-positive patients, all naive to ART and all about to start ART for clinical indications, and 11 healthy, HIV-negative control subjects. Interventions: Assessment of T-cell proliferation and cytokine production after administration of ART to patients with HIV infection. Measurements and results: All patients had a negative tuberculin skin test result at baseline and were anergic. Highly active ART reduced the viral load to very low levels in all patients within a short time after starting therapy. Blood samples were drawn every 2 months after starting therapy, and continued for 1 year while the patients continued to receive ART. There were trends toward increased proliferation of peripheral blood mononuclear cells (PBMCs) in response to Mycobacterium tuberculosis-specific stimuli, but these were delayed until several months of ART had elapsed. Similar trends were noted in relation to the secretion of IFN-gamma. Neither PBMC proliferation nor IFN-gamma secretion reached levels seen in healthy control subjects. No consistent trends in IL-2, IL-10, or IL-12 production were noted. Conclusion: ART restores immune responses to M tuberculosis, although this restoration is delayed and does not reach levels seen in healthy, HIV-negative control subjects. These results may explain in part the phenomenon of paradoxic reactions to antituberculosis therapy in patients with HIV infection. A larger study in which patients are followed up for a longer period of time will allow the magnitude and timing of this reconstitution to be more precisely, defined.
引用
收藏
页码:597 / 602
页数:6
相关论文
共 14 条
  • [1] *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_
  • [2] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease
    Autran, B
    Carcelain, G
    Li, TS
    Blanc, C
    Mathez, D
    Tubiana, R
    Katlama, C
    Debre, P
    Leibowitch, J
    [J]. SCIENCE, 1997, 277 (5322) : 112 - 116
  • [3] BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
  • [4] Clerici M, 2000, ANN NY ACAD SCI, V917, P956
  • [5] Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: Assessment by determination of CD69 expression on T cells after tuberculin stimulation
    Hsieh, SM
    Hung, CC
    Pan, SC
    Wang, JT
    Tsai, HC
    Chen, MY
    Chang, SC
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) : 212 - 220
  • [6] Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
    Kirk, O
    Lundgren, JD
    Pedersen, C
    Nielsen, H
    Gerstoft, J
    [J]. AIDS, 1999, 13 (13) : 1647 - 1651
  • [7] Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy.
    Ledergerber, B
    Mocroft, A
    Reiss, P
    Furrer, H
    Kirk, O
    Bickel, M
    Uberti-Foppa, C
    Pradier, C
    Monforte, AD
    Schneider, MME
    Lundgren, JD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) : 168 - 174
  • [8] Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
    Li, TS
    Tubiana, R
    Katlama, C
    Calvez, V
    Ait Mohand, H
    Autran, B
    [J]. LANCET, 1998, 351 (9117) : 1682 - 1686
  • [9] Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
    Narita, M
    Ashkin, D
    Hollender, ES
    Pitchenik, AE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (01) : 157 - 161
  • [10] Orlovic D, 2001, INT J TUBERC LUNG D, V5, P370